{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:01:05Z","timestamp":1740135665947,"version":"3.37.3"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1245\/s10434-021-10263-z","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T19:02:50Z","timestamp":1623438170000},"page":"9096-9097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ASO Author Reflections: First Do No Harm\u2014Revisiting Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Trials to Reduce the Risk of Peritoneal Metastasis"],"prefix":"10.1245","volume":"28","author":[{"given":"Can","family":"Yurttas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-1317","authenticated-orcid":false,"given":"Markus W.","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"10263_CR1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10049-3","author":"L Bijelic","year":"2021","unstructured":"Bijelic L, Ramos I, Goere D. The Landmark Series: surgical treatment of colorectal cancer peritoneal metastases. Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1245\/s10434-021-10049-3.","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"10263_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/02656736.2016.1227094","volume":"32","author":"AA Tentes","year":"2016","unstructured":"Tentes AA, Stamou K, Pallas N, Karamveri C, Kyziridis D, Hristakis C. The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer. Int J Hyperthermia. 2016;32(8):895\u20139.","journal-title":"Int J Hyperthermia."},{"issue":"2","key":"10263_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366.","journal-title":"Lancet Oncol."},{"issue":"10","key":"10263_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","volume":"4","author":"CEL Klaver","year":"2019","unstructured":"Klaver CEL, Wisselink DD, Punt CJA, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol. 2019;4(10):761\u201370.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"3","key":"10263_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med. 2018;378(3):230\u201340.","journal-title":"N Engl J Med."},{"key":"10263_CR6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10187-8","author":"C Yurttas","year":"2021","unstructured":"Yurttas C, Horvath P, Fischer I, et al. A prospective phase I\/II open label pilot trial to assess the safety of hyperthermic intraperitoneal chemotherapy after oncological resection of pancreatic adenocarcinoma. Ann Surg Oncol. 2021. https:\/\/doi.org\/10.1245\/s10434-021-10187-8.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10263_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12254-020-00653-6","volume":"13","author":"C Yurttas","year":"2020","unstructured":"Yurttas C, Fisher OM, Cort\u00e9s-Guiral D, et al. Cytoreductive surgery and HIPEC in colorectal cancer\u2014did we get hold of the wrong end of the stick. Memo\u2014Magazine of European Medical Oncology. 2020;13(4):434\u20139.","journal-title":"Memo\u2014Magazine of European Medical Oncology"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10263-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T15:05:10Z","timestamp":1636902310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10263-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":7,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10263"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10263-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"18 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.W.L. and A.K. have received a research grant by RanD S.r.l., a manufacturer of devices and consumables for HIPEC, unrelated to the present work. C.Y.\u00a0declares no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"Approval for experimental protocols by the appropriate institutional review committee and adherence to guidelines of the responsible governmental agency do not apply here and were not required for the contents of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}